Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07437820
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years and older;
* Patients with 1 to 12 brain metastases on preoperative MRI, at least one of which (contrast enhancement of at least 1 cm) is accessible for the most complete possible resection (target lesion);
* Patients with a Karnofsky performance score of ≥ 70;
* Patients able to perform neurocognitive tests without assistance;
* Patients who understand the study and agree to attend all visits;
* Patients who have signed a written informed consent form;
* Affiliation with a social security system.
Exclusion Criteria:
* Patient who has already been treated with surgery, radiosurgery, and/or radiotherapy for the target brain metastasis;
* Medical contraindication to MRI;
* Patient with an estimated life expectancy of ≤ 3 months;
* Patients participating in another clinical trial, or who are in the exclusion period of another clinical trial;
* Patients unable to complete a self-administered questionnaire;
* Patients from a vulnerable population.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07437820
Study Brief:
Protocol Section:
NCT07437820